Report overview
Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers.
This report contains market size and forecasts of Celiac Disease Drugs in Global, including the following market information:
Global Celiac Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Celiac Disease Drugs market was valued at 614.6 million in 2021 and is projected to reach US$ 1560.7 million by 2028, at a CAGR of 14.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
First Line of Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Celiac Disease Drugs include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Celiac Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Celiac Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Celiac Disease Drugs Market Segment Percentages, by Type, 2021 (%)
First Line of Treatment
Second Line of Treatment
Global Celiac Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Celiac Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Global Celiac Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Celiac Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Celiac Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Celiac Disease Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
